COURTNEY KAST: Open Payments
NPI 1033874797 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 38 payments from 13 companies in 2025. Trend: 2023 $815 · 2024 $762 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 6 | $204 |
| Novartis Pharmaceuticals Corporation | 10 | $169 |
| Endo USA, Inc. | 5 | $113 |
| Sumitomo Pharma America, Inc. | 5 | $96 |
| Janssen Biotech, Inc. | 3 | $48 |
| ACCORD HEALTHCARE, INC. | 2 | $28 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $26 |
| pharmaand GmbH | 1 | $22 |
| TOLMAR, INC. | 1 | $22 |
| IMMUNITYBIO, INC. | 1 | $21 |
Products named: PROVENGE, PLUVICTO, AVEED, ORGOVYX, ERLEADA, GEMTESA, Rubraca, Camcevi.
Industry payments across OH — which companies pay providers there.
